Bioneer Corporation (KOSDAQ:064550)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,000
+2,210 (25.14%)
Sep 1, 2026, 3:30 PM KST

Bioneer Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
345,882330,111293,975263,237218,394223,744
Other Revenue
---0--0-0
345,882330,111293,975263,237218,394223,744
Revenue Growth
15.87%12.29%11.68%20.53%-2.39%8.09%
Cost of Revenue
80,89073,31674,48760,73752,32350,528
Gross Profit
264,992256,794219,489202,500166,072173,216
Selling, General & Admin
235,825223,946206,275181,642131,670106,632
Research & Development
16,42612,80619,17415,03116,75117,987
Amortization of Goodwill & Intangibles
872.25959.451,077850.85800.4617.63
Other Operating Expenses
2,4081,3521,2181,1951,121848.41
Operating Expenses
258,756241,569232,904201,727155,328126,150
Operating Income
6,23515,225-13,415772.710,74447,066
Interest Expense
-4,561-4,615-3,418-1,408-647.92-641.36
Interest & Investment Income
1,9701,8611,6291,304539.2936.88
Currency Exchange Gain (Loss)
1,018-149.771,12076.44512.831,108
Other Non Operating Income (Expenses)
-581.42-1,605-337.02-356.22774.52-7,771
EBT Excluding Unusual Items
4,08110,717-14,421389.7311,92339,799
Gain (Loss) on Sale of Investments
-776.69-800.12-792.53-494.461,9222,599
Gain (Loss) on Sale of Assets
-15.67-14.8737.752.5616.81834.55
Asset Writedown
---148.96---
Other Unusual Items
---35.1742.6944.8
Pretax Income
3,2889,902-15,325-6713,90443,278
Income Tax Expense
6,9628,1953,7176,852-1,21814,079
Earnings From Continuing Operations
-3,6741,707-19,042-6,91915,12229,199
Minority Interest in Earnings
-2,999-4,520-1,542-3,668-3,045-2,039
Net Income
-6,673-2,813-20,584-10,58712,07727,160
Net Income to Common
-6,673-2,813-20,584-10,58712,07727,160
Net Income Growth
-----55.53%-53.09%
Shares Outstanding (Basic)
262626262625
Shares Outstanding (Diluted)
262626262625
Shares Change
0.81%0.06%-0.06%-2.00%2.99%
EPS (Basic)
-257.51-108.99-798.00-410.19467.911073.38
EPS (Diluted)
-257.51-108.99-798.00-410.19467.911073.00
EPS Growth
-----56.39%-55.40%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-9,656-37,679-26,111-523.93-8,65510,998
Free Cash Flow Per Share
-372.64-1459.85-1012.27-20.30-335.31434.64
Gross Margin
76.61%77.79%74.66%76.93%76.04%77.42%
Operating Margin
1.80%4.61%-4.56%0.29%4.92%21.04%
Profit Margin
-1.93%-0.85%-7.00%-4.02%5.53%12.14%
Free Cash Flow Margin
-2.79%-11.41%-8.88%-0.20%-3.96%4.92%
EBITDA
14,48224,193-4,2879,72618,81452,921
EBITDA Margin
4.19%7.33%-1.46%3.69%8.62%23.65%
D&A For EBITDA
8,2468,9689,1288,9538,0695,855
EBIT
6,23515,225-13,415772.710,74447,066
EBIT Margin
1.80%4.61%-4.56%0.29%4.92%21.04%
Effective Tax Rate
211.73%82.76%---32.53%
Advertising Expenses
-48,70745,71737,62025,96214,326